-
News
Tauriga Sciences Inc. Commences Major Advertising Campaign in Times Square
[ad_1] This Campaign is Focused on the Company’s Flagship Brand: Tauri-Gum™ NEW YORK, NY, – (NewMediaWire) – October 11, 2021…
Read More » -
News
Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
Miami Beach, FL / October 11, 2021 — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company…
Read More » -
News
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity
Shelton, Connecticut — (October 11, 2021) – NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a leader in the development of highly…
Read More » -
News
ReelTime’s Technology License Revenues Increase with Rapidly Expanding Virtual Restaurant Munchie Magic
[ad_1] Seattle, WA – (NewMediaWire) – October 7, 2021 – ReelTime VR/ReelTime Media (OTC PK:RLTR) announced that its revenues from…
Read More » -
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis
[ad_1] Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis…
Read More »